Unique ID issued by UMIN | UMIN000002887 |
---|---|
Receipt number | R000003523 |
Scientific Title | A multicenter study to examine renal protection by a combination of an HMG-CoA reductase inhibitor and losartan in patients with dyslipidemia associated with IgA nephropathy |
Date of disclosure of the study information | 2009/12/14 |
Last modified on | 2017/12/20 09:53:46 |
A multicenter study to examine renal protection by a combination of an HMG-CoA reductase inhibitor and losartan in patients with dyslipidemia associated with IgA nephropathy
LIPS study
A multicenter study to examine renal protection by a combination of an HMG-CoA reductase inhibitor and losartan in patients with dyslipidemia associated with IgA nephropathy
LIPS study
Japan |
IgA nephropathy
Nephrology |
Others
NO
This study will examine inhibition of the progression of renal dysfunction in patients with dyslipidemia associated with IgA nephropathy in a group administered a combination of losartan and a statin and a group administered a statin alone.
Safety,Efficacy
The effectiveness of reducing proteinuria in spot urine samples will be compared in a control group receiving statin therapy alone for 2 years and a treatment group given statin therapy and losartan.
Interventional
Parallel
Randomized
Individual
Open -no one is blinded
Active
NO
NO
Institution is not considered as adjustment factor.
NO
Numbered container method
2
Treatment
Medicine |
statin and losartan group:
simvastatin 5mg and Losartan 50mg/day more than 3 months
statin group:
simvastatin 5mg/day more than 3 months
20 | years-old | <= |
Not applicable |
Male and Female
1.Men and women over the age of 20
2.Patients with dislipidemia(LDL cholesterol: 120 mg/dL or higher)
3.Patients who need a therapy of hypertention (JSH2009)
4.Patients not taking an ACE inhibitor or ARB within the last 3 months
5.Patients who have provided written consent
1.Patients with type 1 diabetes mellitus
2.Patients with cardiovascular disease and with the following conditions
Patients who have undergone coronary artery bypass grafting (CABG) or percutaneous transluminal coronary angioplasty (PTCA) within the last 3 months, patients with unstable angina, patients with a history of myocardial infarction, patients with a history of a transient ischemic attack (TIA) within the last 6 months, patients that are NYHA functional class III or IV or with heart failure, and patients with a history of cerebral infarction within the last 3 months
3. serum Cr>2.5mg/dL or eGFR<30mL/min
4.Patients with severe liver dysfunction
5.Patients with secondary hypertension caused by factors other than diabetes mellitus
6.HbA1c > 9%
7.Patients with pregnancy or nursing
8.Other patients deemed ineligible by an investigator
80
1st name | |
Middle name | |
Last name | Takao Saito |
Fukuoka University Faculty of Medicine
Division of Nephrology and Rheumatology, Department of Internal Medicine
7-45-1, Nanakuma, Jonan-ku, Fukuoka, Japan
+81-92-801-1011
tsaito@fukuoka-u.ac.jp
1st name | |
Middle name | |
Last name | Satoru Ogahara |
Fukuoka University Faculty of Medicine
Division of Nephrology and Rheumatology, Department of Internal Medicine
7-45-1, Nanakuma, Jonan-ku, Fukuoka, Japan
+81-92-801-1011
sogahara@cis.fukuoka-u.ac.jp
Fukuoka University Faculty of Medicine
The Kidney Foundation, Japan
Non profit foundation
Japan
NO
2009 | Year | 12 | Month | 14 | Day |
Unpublished
Enrolling by invitation
2009 | Year | 11 | Month | 01 | Day |
2009 | Year | 12 | Month | 01 | Day |
2012 | Year | 03 | Month | 01 | Day |
2009 | Year | 12 | Month | 14 | Day |
2017 | Year | 12 | Month | 20 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000003523
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |